The Radiation Oncology Market includes a broad range of technologies used to plan, deliver, and monitor radiation treatment for cancer patients. Key technologies include linear accelerators, image-guided radiation therapy, intensity-modulated radiation therapy, stereotactic radiosurgery, stereotactic body radiation therapy, proton therapy, brachytherapy, and treatment-planning software.

Linear accelerators remain central to modern radiation oncology because they can deliver high-energy radiation to targeted areas. Advances in image guidance and treatment planning have improved the ability of clinicians to accurately position patients and focus radiation on tumors. This has encouraged hospitals and cancer centers to upgrade older equipment with newer systems.

Stereotactic techniques are another important area of development. Stereotactic radiosurgery and stereotactic body radiation therapy allow highly focused radiation to be delivered in fewer treatment sessions for selected patients. Proton therapy is also attracting attention because of its potential to reduce radiation exposure to certain surrounding tissues, although its high infrastructure and equipment costs can limit availability.

Radiation oncology is used to treat various cancer types, including breast, prostate, lung, brain, head and neck, colorectal, and other cancers. Hospitals and specialized cancer treatment centers represent major end users because they provide comprehensive oncology services.

Future innovation is likely to emphasize artificial intelligence, adaptive treatment planning, automation, real-time imaging, and integrated oncology information systems. These technologies may improve workflow efficiency and support increasingly individualized treatment strategies.